These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15666160)

  • 1. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy.
    Balabanova Y; Ruddy M; Hubb J; Yates M; Malomanova N; Fedorin I; Drobniewski F
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):136-9. PubMed ID: 15666160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
    Lu PL; Peng CF; Hwang JJ; Chen YH
    J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
    Lu PL; Lee YW; Peng CF; Tsai JJ; Chen YH; Hwang KP; Chen TP
    Int J Antimicrob Agents; 2003 Mar; 21(3):239-43. PubMed ID: 12636985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to second-line drugs in migrants with multidrug-resistant tuberculosis in the Berlin region].
    Otto-Knapp R; Bös L; Schönfeld N; Wagner S; Starzacher AK; Weiss T; Vesenbeckh S; Glaser-Paschke G; Mauch H; Rüssmann H; Bauer TT
    Pneumologie; 2014 Jul; 68(7):496-500. PubMed ID: 25006843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of Drug-Resistant Tuberculosis in Spain (2001-2015).
    Gutiérrez-Aroca JB; Ruiz P; Vaquero M; Causse M; Casal M
    Microb Drug Resist; 2018; 24(6):839-843. PubMed ID: 29608388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.
    Zazueta-Beltran J; León-Sicairos N; Muro-Amador S; Flores-Gaxiola A; Velazquez-Roman J; Flores-Villaseñor H; Canizalez-Roman A
    Int J Infect Dis; 2011 Apr; 15(4):e272-6. PubMed ID: 21317004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis complex strains and drug susceptibility in a cattle-rearing region of Cameroon.
    Kuaban C; Um Boock A; Noeske J; Bekang F; Eyangoh S
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):34-8. PubMed ID: 24365549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.
    Hasan R; Jabeen K; Mehraj V; Zafar F; Malik F; Hassan Q; Azam I; Kadir MM
    Int J Infect Dis; 2009 Nov; 13(6):e377-82. PubMed ID: 19369103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in Kentucky: current recommendations for empiric therapy.
    Wojda B; Ahkee S; Uyamadu N; Jouja K; Ramirez JA
    J Ky Med Assoc; 1997 Mar; 95(3):98-101. PubMed ID: 9071852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.